NEA Management Company, LLC - TRANSCEPT PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
NEA Management Company, LLC ownership history of TRANSCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2014$4,236,000
+2.0%
2,086,7550.0%0.22%
+10.3%
Q2 2014$4,153,000
-35.4%
2,086,7550.0%0.20%
-38.3%
Q1 2014$6,427,000
-8.3%
2,086,7550.0%0.32%
-6.8%
Q4 2013$7,011,000
+5.7%
2,086,7550.0%0.34%
+28.9%
Q3 2013$6,636,000
+5.3%
2,086,7550.0%0.26%
-6.4%
Q2 2013$6,302,0002,086,7550.28%
Other shareholders
TRANSCEPT PHARMACEUTICALS IN shareholders Q4 2014
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,255,691$7,173,0005.84%
NEA Management Company, LLC 2,086,755$6,636,0000.26%
TOURADJI CAPITAL MANAGEMENT, LP 10,000$32,0000.10%
Loeb Offshore Management LP 101,000$321,0000.10%
BVF INC/IL 150,000$477,0000.08%
ABNER HERRMAN & BROCK LLC 20,000$64,0000.04%
SABBY MANAGEMENT, LLC 173,500$552,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 67,000$213,0000.01%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 52,000$165,0000.00%
PANAGORA ASSET MANAGEMENT INC 96,858$307,0000.00%
View complete list of TRANSCEPT PHARMACEUTICALS IN shareholders